Search research articles
Contact Us
Filters
Showing results (371-380 of 397) with videos related to
Page
of 40
Sort By:
The Lancet Regional Health. Europe
|
February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
Michael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
December 13, 2023
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation
Max Bittrich, Katharina Kriegsmann, Carola Tietze-Stolley, et al.
BMC Cancer
|
April 27, 2016
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma
Marc-Andrea Baertsch, Jana Schlenzka, Elias K Mai, et al.
Leukemia
|
July 23, 2020
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE
Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, et al.
Bone Marrow Transplantation
|
May 7, 2026
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee
Roser Velasco, Martin Schmidt-Hieber, Olaf Penack, et al.
Ambio
|
June 13, 2019
Muskox status, recent variation, and uncertain future
Christine Cuyler, Janice Rowell, Jan Adamczewski, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 30, 2023
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, et al.
Science (New York, N.Y.)
|
September 12, 2009
Ecological dynamics across the Arctic associated with recent climate change
Eric Post, Mads C Forchhammer, M Syndonia Bret-Harte, et al.
Eclinicalmedicine
|
March 5, 2026
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
Martin Schmidt-Hieber, Per Ljungman, Patrick Gilbert, et al.
Molecular Ecology
|
November 16, 2023
Population genomics of the muskox' resilience in the near absence of genetic variation
Patrícia Pečnerová, Edana Lord, Genís Garcia-Erill, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 397) with videos related to
Sort By:
Page
of 40
The Lancet Regional Health. Europe
|
February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
Michael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
December 13, 2023
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation
Max Bittrich, Katharina Kriegsmann, Carola Tietze-Stolley, et al.
BMC Cancer
|
April 27, 2016
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma
Marc-Andrea Baertsch, Jana Schlenzka, Elias K Mai, et al.
Leukemia
|
July 23, 2020
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE
Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, et al.
Bone Marrow Transplantation
|
May 7, 2026
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee
Roser Velasco, Martin Schmidt-Hieber, Olaf Penack, et al.
Ambio
|
June 13, 2019
Muskox status, recent variation, and uncertain future
Christine Cuyler, Janice Rowell, Jan Adamczewski, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 30, 2023
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, et al.
Science (New York, N.Y.)
|
September 12, 2009
Ecological dynamics across the Arctic associated with recent climate change
Eric Post, Mads C Forchhammer, M Syndonia Bret-Harte, et al.
Eclinicalmedicine
|
March 5, 2026
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
Martin Schmidt-Hieber, Per Ljungman, Patrick Gilbert, et al.
Molecular Ecology
|
November 16, 2023
Population genomics of the muskox' resilience in the near absence of genetic variation
Patrícia Pečnerová, Edana Lord, Genís Garcia-Erill, et al.
Page
of 40